Neuroendocrine tumours of the pancreas

International Network of bio-banks and expert centres

Translational and tailored, but can we afford it?

The immuno side of melanoma

Constructing successful biomarker clinical trials

Highlights of the 22nd EACR meeting and tackling glioblastoma

The changing field of drug development

Epigenetics of cancer and changes in DNA modification in tumours

Adjuvant cetuximab disappoints again in mCRC

A new direction for development of targeted cancer therapies

Next generation sequencing and WIN therapeutics

Identifying targets with systems medicine